University of Maryland, Baltimore: Hepatitis trials

The registry lists 12 Hepatitis studies with University of Maryland, Baltimore as lead sponsor. 0 are open to participants now and 6 have results posted.

Early Phase 1 2Phase 2 3Phase 3 1Phase 4 6No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C EradicationCompletedNCT03823911Phase 4Results posted
• B/F/TAF Switch Study for HIV-HBV CoinfectionCompletedNCT03797014Phase 4Results posted
• Ledipasvir/Sofosbuvir for Hepatitis B Virus InfectionCompletedNCT03312023Phase 2Results posted
• HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal TransplantCompletedNCT02902120Phase 4Results posted
• Maraviroc Efficacy for Hepatitis CCompletedNCT02881762Phase 4Results posted
• Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA ExperienceCompletedNCT02745535Phase 2Results posted
• Heplisav-B Revaccination for Hepatitis B Vaccine NonrespondersCompletedNCT05791851
• Hepatitis B Vaccine in SeniorsCompletedNCT04162223Early Phase 1
• Hepatitis C Positive Donor Into Hepatitis C Negative RecipientsWithdrawnNCT03702218Early Phase 1
• Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4WithdrawnNCT03381859Phase 4
• Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral HepatitisTerminatedNCT00755950Phase 2/3
• Efficacy of Silymarin for Acute HepatitisCompletedNCT00412763Phase 4